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Building a Better Mouse Pathogen
PAGE 891
Newly emerging infectious diseases are frequently caused by spontaneous mutations
in existing pathogens, thereby modifying their host range. Wollert et al. simulated this
chance occurrence by manipulating the human pathogen Listeria monocytogenes
with the goal of extending the host range to mouse. Based on the structure of Listeria’s
invasion protein InlA in complex with its human receptor E-cadherin, the authors
exchanged two amino acids in InlA, which dramatically increased the affinity for both
the human and the formerly incompatible murine E-cadherin receptors. Once incorpo-
rated into the pathogen’s genome, the substitutions enabled Listeria monocytogenes to
infect the mouse by the oral route, thus creating a versatile animal model of human
listeriosis.
Genetic Culprit for Familial Leukemia
PAGE 879
The heritability of B cell chronic lymphocytic leukemia (CLL) is relatively high; however, no predisposing mutations have
been found to date. Raval et al. now show that reduced expression of death-associated protein kinase 1 (DAPK1) underlies
cases of heritable predisposition to CLL. Furthermore, epigenetic silencing of DAPK1 by DNAmethylation occurs in almost
all sporadic CLL cases. In a family with multiple CLL cases the authors detect a rare, single-nucleotide germline mutation in
the upstream regulatory region of theDAPK1 gene, which leads to a 75% decrease in expression of DAPK1. Thus, reduced
expression ofDAPK1 can result from germline predisposition, as well as from spontaneous epigenetic events that cause or
contribute to the development of CLL.
SUMO Ligase Outwrestles Inflammation
PAGE 903
Unrestricted inflammation is associated with immune disorders and cancer. How inflammatory stimuli signal to the nucleus
to restrict inflammatory gene activation is poorly understood. Here Liu et al. report that proinflammatory stimuli trigger the
rapid phosphorylation of the transcription repressor PIAS1 by the IKKa kinase. They further find that this step requires the
SUMO E3 ligase activity of PIAS1. Phosphorylated PIAS1 is then recruited to the chromatin to inhibit the binding of NF-kB/
STAT1 to gene promoters, resulting in the repression of inflammatory gene activation. The IKKa-PIAS1 pathway thus
represents a previously unidentified signaling mechanism to restrict inflammation and innate immunity.
Tumor Suppressor Impacts Compaction
PAGE 915
Silencing of gene expression is partially achieved by transient or stable condensa-
tion of the chromatin structure, which renders DNA inaccessible to the transcription
machinery. Histone lysinemethylationmarks are involved in the formation andmain-
tenance of heterochromatin. Here, Trojer et al. show that the transcriptional repres-
sor and tumor suppressor L3MBTL1 compacts chromatin by binding to two or more
nucleosomes. This binding is dependent on specificmono- and dimethylationmarks
on histones H4 and H1b. Furthermore, L3MBTL1 complexes with core histones,
histone H1, HP1g, and the transcriptional repressor Rb and negatively regulates
genes expression. Thus, L3MBTL1 coordinates the formation of heterochromatin
with transcriptional repression.
Releasing the Ribosome
PAGE 929
Translation termination in prokaryotes is mediated by class I (RF1/RF2) and class II (RF3) release factors, in which the role
of RF3 is to promote rapid dissociation of RF1/RF2 thereby rendering the ribosome ready for the next round of translation.
Gao et al. report an atomic structure of RF3, a biochemical analysis of RF3 mutants, and a cryo-EM structure of the
RF3-bound ribosome. The results support a mechanism of RF3-dependent translation termination in which the release
of RF1/RF2 is caused by the large conformational changes in the ribosome. These changes are induced by the binding
of RF3GTP, which breaks the interactions of RF1/RF2 with ribosome at both the decoding center and the GTPase-
associated center.Cell 129, June 1, 2007 ª2007 Elsevier Inc. 839
Watching Proteins Go Retro In Vitro
PAGE 943
Secretory proteins unable to assemble into their native states in the endoplasmic reticulum (ER) are transported back
or ‘‘retro-translocated’’ into the cytosol for ER-associated degradation (ERAD). To examine the roles of different ERAD
components, Wahlman et al. have developed an in vitro spectroscopic approach that directly monitors the movement of
fluorescent-labeled ERAD substrates through an ER membrane. By measuring kinetics continuously in real time, and by
varying the lumenal, cytosolic, and membrane components, the contributions of individual proteins that were required
for maximal retro-translocation of the nonglycosylated pro-a-factor substrate were quantified. Interestingly, retro-translo-
cation was blocked by antibodies against the putative retro-translocation channel protein Derlin-1, but not Sec61a, thus
further implicating Derlin-1 in retro-translocation.
PI3-Kinase Mutant Tames Ras Tumorigenesis
PAGE 957
Ras oncogenes are activated in many human tumors. In vitro they signal through direct interaction with target enzymes,
including Raf and phosphoinositide (PI) 3-kinases, although genetic evidence for the importance of the interaction with
PI 3-kinase in tumor formation has been lacking. NowGupta et al. have generatedmicewithmutations in the gene encoding
the p110a isoform of PI 3-kinase that block its interaction with Ras. These animals are highly resistant to endogenous Ras
oncogene-induced tumorigenesis. The interaction of Raswith p110a is thus required in vivo for certain normal growth factor
signaling and for Ras-driven tumor formation.
‘‘Ral’’lying Tumor Suppression by PP2A
PAGE 969
ThePP2A family of ubiquitously expressed serine-threonine phosphatases regulates
many signaling pathways, and its members are known to be important tumor sup-
pressors. Mutations of the PP2A Ab subunit occur in several types of human tumors;
however, the functional consequencesof thesecancer-associatedmutations remain
undefined. Now Sablina et al. show that PP2A Ab binds to and inhibits the small
GTPase RalA. PP2A Ab regulates the phosphorylation status of two serine residues
in RalA, both of which are required for the transforming activity of RalA, and cancer
cell lines that lack PP2A Ab show increased RalA activity. Thus the authors propose
a newmechanism for PP2A-mediated tumor suppression via the inhibition of a small,
oncogenic GTPase.
Bringing Cells back from the Brink of Death, Again
PAGE 983
Cells that undergo mitochondrial outer membrane permeabilization (MOMP) engage apoptosis via caspase activation.
However, even if caspase engagement is blocked or disrupted, death ensues via caspase-independent cell death
(CICD). Colell et al. find that glyceraldehyde-3-phosphate dehydrogenase—GAPDH—could protect cells from CICD but
not apoptosis, and remarkably, this protection was observed in cells that had undergone MOMP. The effect involves an
autophagic process that appears to remove damagedmitochondria. The avoidance of CICD has implications for oncogen-
esis, as many tumors show defects in caspase activation downstream of MOMP.
Stemness Hierarchy in Muscle Satellite Cells
PAGE 999
The growth and robust regeneration of skeletal muscles are powered by muscle progenitors called satellite cells. Satellite
cells can not only develop into muscle but also self-renew to ensure a sustained regenerative capacity. However, whether
satellite cells are stem cells, committed progenitors, or de-differentiated myoblasts has remained unclear. Using genetic
lineage analysis, Kuang et al. demonstrate that the satellite cell pool is composed of hierarchical subpopulations of
stem and committed cells. Furthermore, the stem cells maintain the homeostasis of the satellite cell pool through highly
regulated asymmetric cell-fate segregation. Finally, transplanted stem cells effectively repopulate host muscles, suggest-
ing their potential applications in cell-based therapies to treat muscular dystrophies.
Working Overtime Sets the Clock
PAGE 1011
The circadian clock influences the daily oscillations of physiological processes in different organisms. The length of the
circadian cycle is determined in part by the cyclic accumulation of transcriptional repressors, the Cryptochrome (Cry) and
Period (Per) proteins. Siepka et al. now report a novel circadian mouse mutant Overtime. They find that loss of FBXL3, an
F-box protein and component of an E3 ubiquitin ligase complex, in the Overtime mutant leads to the stabilization of Cry
protein levels and a global repression of target gene transcription, extending the circadian rhythm of the mice. FBXL3
interacts specifically with Cry, targeting it for proteasomal degradation. These findings uncover a role for regulated Cry
degradation in regulating circadian rhythms and define FBXL3 as a new molecular component of the circadian clock.Cell 129, June 1, 2007 ª2007 Elsevier Inc. 841
